Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Gudaye Tasissa"'
Autor:
Jennifer A. Rymer, Deepak L. Bhatt, Dominick J. Angiolillo, Miguel Diaz, Kirk N. Garratt, Ron Waksman, Laura Edwards, Gudaye Tasissa, Khalid Salahuddin, Hijrah El‐Sabae, Carmen Dell’Anna, Linda Davidson‐Ray, Jeffrey B. Washam, E. Magnus Ohman, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention–related ischemic complications without increasing major bleeding. This study was performed to examine cangrelor use and transition to oral P2Y12 in
Externí odkaz:
https://doaj.org/article/dd326c0c0df844739daea9df80309174
Autor:
Jennifer A. Rymer, Deepak L. Bhatt, Dominick J. Angiolillo, Miguel Diaz, Kirk N. Garratt, Ron Waksman, Laura Edwards, Gudaye Tasissa, Khalid Salahuddin, Hijrah El‐Sabae, Carmen Dell’Anna, Linda Davidson‐Ray, Jeffrey B. Washam, E. Magnus Ohman, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association. 11
Background In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention–related ischemic complications without increasing major bleeding. This study was performed to examine cangrelor use and transition to oral P2Y 12 i
Autor:
Abraham Salacata, Wayne Old, Ileana L. Piña, David D. Lanfear, Gudaye Tasissa, John F. Heitner, Adam D. DeVore, Adrian F. Hernandez, Robert T. Cole, Robert Bigelow, Gregg C. Fonarow, Robert J. Mentz, Chetan B. Patel, Mahazarin Ginwalla, Anuradha Lala
Publikováno v:
American Heart Journal. 223:98-105
Background Ivabradine is guideline-recommended to reduce heart failure (HF) hospitalization in patients with stable chronic HF with reduced ejection fraction (EF). Ivabradine initiation following acute HF has had limited evaluation, and there are few
Autor:
Jennifer Rymer, Deepak L. Bhatt, Dominick J. Angiolillo, Miguel A. Diaz, Kirk N. Garratt, Ron Waksman, Laura Edwards, Gudaye Tasissa, Khalid Salahuddin, Hijrah El-Sabae, Carmen Dell’Anna, Linda Davidson-Ray, Jeffrey B. Washam, Erik Magnus Ohman, Tracy Wang
Publikováno v:
Journal of the American College of Cardiology. 79:1063
Autor:
Mark D Rothenberg, Hussein R. Al-Khalidi, Diane Joseph, Mitchell W. Krucoff, David F. Kong, Shigeru Nakamura, Shigeru Saito, Gudaye Tasissa, Hiram G. Bezerra, Barry D. Bertolet, Akiko Maehara, Roxana Mehran, Philippe Généreux, Yumiko Okaniwa, Yoshisato Shibata, Stephen M. Rowland, Debbie Morrell
Publikováno v:
European Heart Journal
Aims Harmonized Assessment by Randomized Multicentre Study of OrbusNEich’s Combo StEnt (HARMONEE) (NCT02073565) was a randomized pivotal registration trial of the Combo stent, which combined sirolimus and an abluminal bioabsorbable polymer with a n
Autor:
Amy Blase, Kevin J. Anstrom, David J. Whellan, Holger Woehrle, Mona Fiuzat, JoAnn Lindenfeld, Olaf Oldenburg, Christopher M. O'Connor, Gudaye Tasissa, Adam Benjafield, Naresh M. Punjabi
Publikováno v:
Journal of the American College of Cardiology. 69:1577-1587
Background Sleep apnea is common in hospitalized heart failure (HF) patients and is associated with increased morbidity and mortality. Objectives The CAT-HF (Cardiovascular Improvements With MV-ASV Therapy in Heart Failure) trial investigated whether
Autor:
Mahazarin Ginwalla, Ileana L. Piña, Anuradha Lala, David E Lanfear, Robert Bigelow, Tim Peterson, Adrian F. Hernandez, Abraham Salacata, Gregg C. Fonarow, Chetan B. Patel, Wayne Old, Adam D. DeVore, Gudaye Tasissa, John F. Heitner, Robert J. Mentz, Robert T. Cole
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 12
Background: Prior studies suggest that the hospital setting provides an important opportunity to initiate guideline-directed medical therapy (GDMT) for patients with heart failure with reduced ejection fraction (HFrEF). Ivabradine is a specific inhib
Autor:
Jonathan P. Piccini, Adam Benjafield, Gudaye Tasissa, Naresh M. Punjabi, Christopher M. O'Connor, JoAnn Lindenfeld, Sean D. Pokorney, Holger Woehrle, Olaf Oldenburg, Kevin J. Anstrom, Mona Fiuzat, David J. Whellan, Amy Blase
Publikováno v:
Heart rhythm. 16(1)
Background Patients with heart failure and sleep apnea are at increased risk for developing arrhythmias. Whether treatment of sleep apnea reduces arrhythmias is unknown. Objective The purpose of this study was to determine whether adaptive servo-vent
Autor:
Adam Benjafield, Naresh M. Punjabi, Amy Blase, Melissa A. Daubert, Holger Woehrle, David J. Whellan, Mona Fiuzat, Kevin J. Anstrom, JoAnn Lindenfeld, Gudaye Tasissa, Christopher M. O'Connor, Olaf Oldenburg
Publikováno v:
American heart journal. 201
Background Sleep-disordered breathing (SDB), including central and obstructive sleep apnea, is a marker of poor prognosis in heart failure (HF) and may worsen cardiac dysfunction over time. Treatment of SDB with adaptive servoventilation (ASV) may re
Autor:
Christopher M, O'Connor, David J, Whellan, Mona, Fiuzat, Naresh M, Punjabi, Gudaye, Tasissa, Kevin J, Anstrom, Adam V, Benjafield, Holger, Woehrle, Amy B, Blase, JoAnn, Lindenfeld, Olaf, Oldenburg
Publikováno v:
Journal of the American College of Cardiology. 69(12)
Sleep apnea is common in hospitalized heart failure (HF) patients and is associated with increased morbidity and mortality.The CAT-HF (Cardiovascular Improvements With MV-ASV Therapy in Heart Failure) trial investigated whether minute ventilation (MV